Top Penny Stocks Today: Here’s Why NVCT Stock Is Moving

Traders love penny stocks, especially if they’re making big moves. In the stock market today, there are plenty to choose from. Having an eye for opportunity, knowing how to read charts, and understanding what volatile can do to stocks comes in handy. However, the first step is finding out why certain penny stocks are moving.

Is there a big breakout going on right now? Is it due to the market as a whole, or does it have anything to do with industry-specific trends? Are insiders buying, or is it a technical move based on a short squeeze? There are many questions to have answers for when it comes to learning why some penny stocks move the way they do. For example, several Trump Stocks were exploding because one company announced a big update.

CF Acquisition Corp. VI (NASDAQ: CFVI), the proposed home of video media platform Rumble, came into the spotlight after news surfaced that the company would offer Joe Rogan a 4-year, $100 million deal to join Rumble and not face censorship. This has been a hot topic that has triggered a response from mainstream social media as becoming too censored. Heightened concern has grown since Rogan’s podcast was said to face removal from platforms like Spotify due to “misinformation” discussed on his show.

Trump Stocks Gain On CFVI Stock Sympathy Sentiment

Following the surge in buying of CFVI stock today, other Trump-related names also moved in kind. In particular, the proposed new home of Trump Media, Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped to highs of over $96 thanks to sympathy momentum. It was also helped by continued speculation on the formal launch of the Trump Social Media App expected later this month.

Why mention this? The point here is to show that one company announcing something can significantly impact the market reaction of another. The DWAC and CFVI stock moves have also sparked intrigue in low float stocks.

For those who may be newer to the markets, “low float” stocks are ones with fewer shares traded in public hands. As a result, higher demand with lower supply creates the classic economic scenario of higher prices. It also usually involves very volatile swings in the market. This may have trickled over into other names like newly IPOed Nuvectis Pharma Inc. (NASDAQ: NVCT) in the stock market today.

What To Know About Nuvectis Pharma Inc. (NASDAQ: NVCT)

The company went public last week in a $16 million IPO from the sale of 3.2 million shares. On day-1 of trading, NVCT stock flopped, as many will see. The IPO price was $5, the stock opened at $3.95 and fell to $3.08, 38% lower than the IPO price. However, on day-2 of its public debut, NVCT stock likely outperformed expectations after surging to highs of over $10 before the end of the lunchtime session.

As a biotech company, Nuvectis plans to use the IPO funding to advance its pipeline. Specifically, proceeds were earmarked to fund the Phase 1/2 development of the company’s NXP800 as well as supporting an Investigational New Drug-enabling study of NXP900 and continue sponsored research of additional product candidates.

NVCT Stock News

While no news has been released this week, the devil is in the details, as the saying goes. When it comes to biotech penny stocks, you’ve got to pay attention to more than just company headlines. Everything from industry news and corporate filings to FDA and US Patent sites are places to look. In this case, Nuvectis spiked following new details that emerged on the ClinicalTrials website.

Specifically, it showed a new post, dated February 7, titled: A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers. According to the Brief Summary, “The purpose of this dose escalation study is to evaluate the safety profile of escalating doses and dose schedules of NXP800.”

nvct stock FDA trial NXP800

Study design information has 17 patients set for the estimated enrollment cohort and the study start date set at the end of December last year. Seven dose levels are planned, beginning with a dose of 50mg once per day and up to a max planned dose of 150 mg twice per day.

NVCT Stock Price Action

NVCT stock is on fire to start the week. This low float penny stock has demonstrated how aggressive breakouts can become with higher inflows of buying activity. At the beginning of the session, NVCT was still considered a penny stock, trading at $3.45. Since then, share prices have climbed to over $10.30 as of this article. Despite the failed IPO day, NVCT’s stock price has surged over 230%, from lows on February 4 to highs of $10.35 on February 7.

best penny stocks to buy Nuvectis Pharma NVCT stock chart
2-Day, 15-minute NVCT Stock Chart (2/4-2/7)

Read More On NVCT Stock:

  1. NVCT Stock Profile
  2. NVCT Stock News
  3. SEC Filings
  4. NVCT Price History

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom
Privacy Policy

Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146 |

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

4 Penny Stocks To Buy For Under $3.50; What Do Analysts Think?

Penny Stocks To Buy For Under $3.50 But Are They Worth The Risk?

5 Gold Stocks To Watch For July

NOTICE: We have recently been made aware of comments which falsely claim…